Walleye Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.1K Sell
7,820
-15,491
-66% -$117K ﹤0.01% 5475
2026
Q2
$243K Buy
+23,311
New +$260K ﹤0.01% 3348
2026
Q1
– Sell
-184,966
Closed -$1.84M – 4328
2025
Q4
$1.84M Buy
184,966
+150,297
+434% +$1.44M 0.01% 1943
2025
Q3
$310K Buy
34,669
+24,080
+227% +$223K ﹤0.01% 2987
2025
Q2
$100K Buy
+10,589
New +$93.4K ﹤0.01% 3772
2024
Q2
– Sell
-122,023
Closed -$1.4M – 5530
2024
Q1
$1.4M Sell
122,023
-1,275
-1% -$10.8K ﹤0.01% 2262
2023
Q4
$899K Buy
+123,298
New +$972K ﹤0.01% 2442
2022
Q2
– Sell
-23,557
Closed -$378K – 2318
2022
Q1
$378K Buy
+23,557
New +$424K 0.01% 1164

Other funds holding AHCO

Walleye Capital's AHCO Position: Q3 2026 in Review

Walleye Capital reduced its AdaptHealth (AHCO) stake by 66% in Q3 2026, selling an estimated $117K and leaving 7,820 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5475.

Walleye Capital first reported a position in AHCO in Q1 2022 and has held it in 8 quarters since. The position peaked at $1.84M in Q4 2025. 248 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Walleye Capital held 7,820 shares of AdaptHealth worth $44.1K as of Q3 2026.
  • Walleye Capital sold 15,491 AdaptHealth shares in Q3 2026, an estimated $117K.
  • AdaptHealth made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5475 holding.
  • Walleye Capital first reported a position in AdaptHealth in Q1 2022 and has held it in 8 quarters since.
  • Walleye Capital's AdaptHealth position peaked at $1.84M in Q4 2025.
  • 248 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.